🔎 Trials Near Me

Akèy › Dyabèt Tip 2 › Nevada › Las Vegas

Etid klinik pou Dyabèt Tip 2 nan Las Vegas, NV

18 etid pou Dyabèt Tip 2 ap chèche patisipan nan sit nan ak bò kote Las Vegas (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Ap rekriteFaz 2
  • Excel Clinical Research, LLC, Las Vegas
  • Palm Research Center Tenaya, Las Vegas
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07783802

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

Ap rekriteFaz 3
  • Palm Research Center Inc-Vegas, Las Vegas
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07817251

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Ap rekriteFaz 3
  • Las Vegas Clinical Trials, Las Vegas
  • AB Clinical Trials, Las Vegas
  • Palm Research Center, Las Vegas
  • ak 2 plis
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

Ap rekriteFaz 3
  • Palm Research Center, Las Vegas
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07754461

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

Ap rekriteVolontè an sante akeyi
  • Southwest Medical Associates- Optum Nevada, Las Vegas
  • Vector Clinical Trials, Las Vegas
Laj 55 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06112418

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Ap rekriteFaz 3
  • AURORA-2 Clinical Site, Las Vegas
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743450

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

Ap rekriteFaz 2
  • DaVita Clinical Research, Las Vegas
Laj 18 a 80 · Tout sèks · Mizajou Sep 11, 2026 · NCT07271186

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Ap rekriteFaz 2
  • Alliance Clinical - Las Vegas, Las Vegas
  • Palm Research Center, Inc., Las Vegas
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07296484

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Ap rekriteFaz 2
  • Vector Clinical Trials, Las Vegas
Laj 18 a 75 · Tout sèks · Mizajou Sep 8, 2026 · NCT07215559

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Ap rekriteFaz 3
  • Palm Research Center Inc, Las Vegas
Laj 18 a 99 · Tout sèks · Mizajou Sep 3, 2026 · NCT07684144

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

Ap rekriteFaz 2
  • Santa Rosa Medical Centers of Nevada, Las Vegas
Laj 18 a 75 · Tout sèks · Mizajou Aug 17, 2026 · NCT07527650

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

Ap rekriteFaz 2
  • Excel Clinical Research, Las Vegas
Laj 18 a 70 · Tout sèks · Mizajou Jun 15, 2026 · NCT07502508

HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

Ap rekriteFaz 2
  • Alliance Clinical Las Vegas (Excel Clinical Research), Las Vegas
Laj 18 ak plis · Tout sèks · Mizajou Apr 23, 2026 · NCT07546929

Etid Dyabèt Tip 2 nan lòt vil

Lòt etid nan Las Vegas

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.